The DOI matches its Crossref record; 112 of the 112 references it cites were found in a registry or an index.
B7 family checkpoint regulators in immune regulation and disease
Open accessAbstract
Fine-tuning the immune response and maintaining tolerance to self antigens involves a complex network of co-stimulatory and co-inhibitory molecules. The recent FDA approval of ipilimumab, a monoclonal antibody blocking CTLA-4, demonstrates the impact of checkpoint regulators in disease. This is reinforced by ongoing clinical trials targeting not only CTLA-4, but also the PD-1 and B7-H4 pathways in various disease states. Recently two new B7 family inhibitory ligands, VISTA and B7-H6 were identified. Here we review recent understanding of B7 family members and their concerted regulation of the immune response to either self or foreign pathogens. We also discuss clinical developments in targeting these pathways in different disease settings, and introduce VISTA as a putative therapeutic target.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
PD-1 and PD-L1 Immune Checkpoint Blockade to Treat Breast Cancer
Hartkopf, A. D., Taran, F.-A., Wallwiener, M., Walter, C. B., Krämer, B., Grischke, E.-M., & Brucker, S. Y. (2016) · Breast Care · doi:10.1159/000453569 · Cited by 30,845
Adverse Renal Effects of Immune Checkpoint Inhibitors: A Narrative Review
Wanchoo, R., Karam, S., Uppal, N. N., Barta, V. S., Deray, G., Devoe, C., Launay-Vacher, V., Jhaveri, K. D., & on behalf of Cancer and Kidney International Network Workgroup on Immune Checkpoint Inhibitors (2017) · American Journal of Nephrology · doi:10.1159/000455014 · Cited by 15,256
Improved Survival with Ipilimumab in Patients with Metastatic Melanoma
Hodi, F. S., O'Day, S. J., McDermott, D. F., Weber, R. W., Sosman, J. A., Haanen, J. B., Gonzalez, R., Robert, C., Schadendorf, D., Hassel, J. C., et al. (2010) · New England Journal of Medicine · doi:10.1056/nejmoa1003466 · Cited by 15,155
Safety, activity, and immune correlates of anti–PD-1 antibody in cancer
Topalian, S. L., Hodi, F. S., Brahmer, J. R., Gettinger, S. N., Smith, D. C., McDermott, D. F., Powderly, J. D., Carvajal, R. D., Sosman, J. A., Atkins, M. B., et al. (2012) · New England Journal of Medicine · doi:10.1056/nejmoa1200690 · Cited by 12,628
PD-1 and Its Ligands in Tolerance and Immunity
Keir, M. E., Butte, M. J., Freeman, G. J., & Sharpe, A. H. (2008) · Annual Review of Immunology · doi:10.1146/annurev.immunol.26.021607.090331 · Cited by 5,378
A distinct lineage of CD4 T cells regulates tissue inflammation by producing interleukin 17
Park, H., Li, Z., Yang, X. O., Chang, S. H., Nurieva, R., Wang, Y.-H., Wang, Y., Hood, L., Zhu, Z., Tian, Q., et al. (2005) · Nature Immunology · doi:10.1038/ni1261 · Cited by 4,265
Brahmer, J. R., Drake, C. G., Wollner, I., Powderly, J. D., Picus, J., Sharfman, W. H., Stankevich, E., Pons, A., Salay, T. M., McMiller, T. L., et al. (2010) · Journal of Clinical Oncology · doi:10.1200/jco.2009.26.7609 · Cited by 2,961
Lymphoproliferative Disorders with Early Lethality in Mice Deficient in Ctla-4
Waterhouse, P., Penninger, J. M., Timms, E., Wakeham, A., Shahinian, A., Lee, K. P., Thompson, C. B., Griesser, H., & Mak, T. W. (1995) · Science · doi:10.1126/science.270.5238.985 · Cited by 2,766
Nishimura, H., Nose, M., Hiai, H., Minato, N., & Honjo, T. (1999) · Immunity · doi:10.1016/s1074-7613(00)80089-8 · Cited by 2,749
CTLA-4 can function as a negative regulator of T cell activation
Walunas, T. L., Lenschow, D. J., Bakker, C. Y., Linsley, P. S., Freeman, G. J., Green, J. M., Thompson, C. B., & Bluestone, J. A. (1994) · Immunity · doi:10.1016/1074-7613(94)90071-x · Cited by 2,222
Cytokine Storm in a Phase 1 Trial of the Anti-CD28 Monoclonal Antibody TGN1412
Suntharalingam, G., Perry, M. R., Ward, S., Brett, S. J., Castello-Cortes, A., Brunner, M. D., & Panoskaltsis, N. (2006) · New England Journal of Medicine · doi:10.1056/nejmoa063842 · Cited by 2,164 · cited 1×
“9 Suntharalingam, G. et al. (2006) Cytokine storm in a phase 1 trial of the anti-CD28 monoclonal antibody TGN1412.”
CTLA-4 and PD-1 Receptors Inhibit T-Cell Activation by Distinct Mechanisms
Parry, R. V., Chemnitz, J. M., Frauwirth, K. A., Lanfranco, A. R., Braunstein, I., Kobayashi, S. V., Linsley, P. S., Thompson, C. B., & Riley, J. L. (2005) · Molecular and Cellular Biology · doi:10.1128/mcb.25.21.9543-9553.2005 · Cited by 1,931
Autoimmune Dilated Cardiomyopathy in PD-1 Receptor-Deficient Mice
Nishimura, H., Okazaki, T., Tanaka, Y., Nakatani, K., Hara, M., Matsumori, A., Sasayama, S., Mizoguchi, A., Hiai, H., Minato, N., et al. (2001) · Science · doi:10.1126/science.291.5502.319 · Cited by 1,868
Trans-endocytosis of CD80 and CD86: a molecular basis for the cell-extrinsic function of CTLA-4
Qureshi, O. S., Zheng, Y., Nakamura, K., Attridge, K., Manzotti, C., Schmidt, E. M., Baker, J., Jeffery, L. E., Kaur, S., Briggs, Z., et al. (2011) · Science · doi:10.1126/science.1202947 · Cited by 1,860 · cited 8×
“28 Waterhouse, P. et al. (1995) Lymphoproliferative disorders with early lethality in mice deficient in Ctla-4.”
InfluentialButte, M. J., Keir, M. E., Phamduy, T. B., Sharpe, A. H., & Freeman, G. J. (2007) · Immunity · doi:10.1016/j.immuni.2007.05.016 · Cited by 1,732
ICOS is an inducible T-cell co-stimulator structurally and functionally related to CD28
Hutloff, A., Dittrich, A. M., Beier, K. C., Eljaschewitsch, B., Kraft, R., Anagnostopoulos, I., & Kroczek, R. A. (1999) · Nature · doi:10.1038/16717 · Cited by 1,482
CD28 costimulation can promote T cell survival by enhancing the expression of Bcl-xL
Boise, L. H., Minn, A. J., Noel, P. J., June, C. H., Accavitti, M. A., Lindsten, T., & Thompson, C. B. (1995) · Immunity · doi:10.1016/1074-7613(95)90161-2 · Cited by 1,210
T Cell Activation Determined by T Cell Receptor Number and Tunable Thresholds
Viola, A., & Lanzavecchia, A. (1996) · Science · doi:10.1126/science.273.5271.104 · Cited by 1,023
B7-H3: A costimulatory molecule for T cell activation and IFN-γ production
Chapoval, A. I., Ni, J., Lau, J. S., Wilcox, R. A., Flies, D. B., Liu, D., Dong, H., Sica, G. L., Zhu, G., Tamada, K., et al. (2001) · Nature Immunology · doi:10.1038/85339 · Cited by 1,015
Choi, Y. S., Kageyama, R., Eto, D., Escobar, T. C., Johnston, R. J., Monticelli, L., Lao, C., & Crotty, S. (2011) · Immunity · doi:10.1016/j.immuni.2011.03.023 · Cited by 958
ICOS co-stimulatory receptor is essential for T-cell activation and function
Dong, C., Juedes, A. E., Temann, U.-A., Shresta, S., Allison, J. P., Ruddle, N. H., & Flavell, R. A. (2001) · Nature · doi:10.1038/35051100 · Cited by 936
BTLA is a lymphocyte inhibitory receptor with similarities to CTLA-4 and PD-1
Watanabe, N., Gavrieli, M., Sedy, J. R., Yang, J., Fallarino, F., Loftin, S. K., Hurchla, M. A., Zimmerman, N., Sim, J., Zang, X., et al. (2003) · Nature Immunology · doi:10.1038/ni944 · Cited by 883
The Programmed Death-1 (PD-1) Pathway Regulates Autoimmune Diabetes in Nonobese Diabetic (NOD) Mice
Ansari, M. J. I., Salama, A. D., Chitnis, T., Smith, R. N., Yagita, H., Akiba, H., Yamazaki, T., Azuma, M., Iwai, H., Khoury, S. J., et al. (2003) · The Journal of Experimental Medicine · doi:10.1084/jem.20022125 · Cited by 814
T-cell co-stimulation through B7RP-1 and ICOS
Yoshinaga, S. K., Whoriskey, J. S., Khare, S. D., Sarmiento, U., Guo, J., Horan, T., Shih, G., Zhang, M., Coccia, M. A., Kohno, T., et al. (1999) · Nature · doi:10.1038/45582 · Cited by 777
B7-H4, a Molecule of the B7 Family, Negatively Regulates T Cell Immunity
Sica, G. L., Choi, I.-H., Zhu, G., Tamada, K., Wang, S.-D., Tamura, H., Chapoval, A. I., Flies, D. B., Bajorath, J., & Chen, L. (2003) · Immunity · doi:10.1016/s1074-7613(03)00152-3 · Cited by 713
VISTA, a novel mouse Ig superfamily ligand that negatively regulates T cell responses
Wang, L., Rubinstein, R., Lines, J. L., Wasiuk, A., Ahonen, C., Guo, Y., Lu, L.-F., Gondek, D., Wang, Y., Fava, R. A., et al. (2011) · Journal of Experimental Medicine · doi:10.1084/jem.20100619 · Cited by 710
Self-citationBrandt, C. S., Baratin, M., Yi, E. C., Kennedy, J., Gao, Z., Fox, B., Haldeman, B., Ostrander, C. D., Kaifu, T., Chabannon, C., et al. (2009) · Journal of Experimental Medicine · doi:10.1084/jem.20090681 · Cited by 706
Berger, R., Rotem-Yehudar, R., Slama, G., Landes, S., Kneller, A., Leiba, M., Koren-Michowitz, M., Shimoni, A., & Nagler, A. (2008) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-07-4079 · Cited by 680
Cutting Edge: CD28 Controls Peripheral Homeostasis of CD4+CD25+ Regulatory T Cells
Tang, Q., Henriksen, K. J., Boden, E. K., Tooley, A. J., Ye, J., Subudhi, S. K., Zheng, X. X., Strom, T. B., & Bluestone, J. A. (2003) · The Journal of Immunology · doi:10.4049/jimmunol.171.7.3348 · Cited by 670
Treatment of Murine Lupus with CTLA4Ig
Finck, B. K., Linsley, P. S., & Wofsy, D. (1994) · Science · doi:10.1126/science.7520604 · Cited by 668
Orban, T., Bundy, B., Becker, D. J., DiMeglio, L. A., Gitelman, S. E., Goland, R., Gottlieb, P. A., Greenbaum, C. J., Marks, J. B., Monzavi, R., et al. (2011) · The Lancet · doi:10.1016/s0140-6736(11)60886-6 · Cited by 612
Liakou, C. I., Kamat, A., Tang, D. N., Chen, H., Sun, J., Troncoso, P., Logothetis, C., & Sharma, P. (2008) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0806075105 · Cited by 549
The CD28-Related Molecule ICOS Is Required for Effective T Cell–Dependent Immune Responses
Coyle, A. J., Lehar, S., Lloyd, C., Tian, J., Delaney, T., Manning, S., Nguyen, T., Burwell, T., Schneider, H., Gonzalo, J. A., et al. (2000) · Immunity · doi:10.1016/s1074-7613(00)00011-x · Cited by 520
Salama, A. D., Chitnis, T., Imitola, J., Ansari, M. J. I., Akiba, H., Tushima, F., Azuma, M., Yagita, H., Sayegh, M. H., & Khoury, S. J. (2003) · The Journal of Experimental Medicine · doi:10.1084/jem.20022119 · Cited by 506
B7h, a Novel Costimulatory Homolog of B7.1 and B7.2, Is Induced by TNFα
Swallow, M. M., Wallin, J. J., & Sha, W. C. (1999) · Immunity · doi:10.1016/s1074-7613(00)80117-x · Cited by 453
CD28/B7 Costimulation: A Review
Greenfield, E. A., Nguyen, K. A., & Kuchroo, V. K. (1998) · Critical Reviews™ in Immunology · doi:10.1615/critrevimmunol.v18.i5.10 · Cited by 441
McAdam, A. J., Chang, T. T., Lumelsky, A. E., Greenfield, E. A., Boussiotis, V. A., Duke-Cohan, J. S., Chernova, T., Malenkovich, N., Jabs, C., Kuchroo, V. K., et al. (2000) · The Journal of Immunology · doi:10.4049/jimmunol.165.9.5035 · Cited by 440
B7S1, a Novel B7 Family Member that Negatively Regulates T Cell Activation
Prasad, D. V. R., Richards, S., Mai, X. M., & Dong, C. (2003) · Immunity · doi:10.1016/s1074-7613(03)00147-x · Cited by 431
Small, E. J., Tchekmedyian, N. S., Rini, B. I., Fong, L., Lowy, I., & Allison, J. P. (2007) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-06-2318 · Cited by 407
B7x: A widely expressed B7 family member that inhibits T cell activation
Zang, X., Loke, P., Kim, J., Murphy, K., Waitz, R., & Allison, J. P. (2003) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1434299100 · Cited by 405
Yuan, J., Adamow, M., Ginsberg, B. A., Rasalan, T. S., Ritter, E., Gallardo, H. F., Xu, Y., Pogoriler, E., Terzulli, S. L., Kuk, D., et al. (2011) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1110814108 · Cited by 332
Eastwood, D., Findlay, L., Poole, S., Bird, C., Wadhwa, M., Moore, M., Burns, C., Thorpe, R., & Stebbings, R. (2010) · British Journal of Pharmacology · doi:10.1111/j.1476-5381.2010.00922.x · Cited by 300
Characterization of Mouse and Human B7-H3 Genes
Sun, M., Richards, S., Prasad, D. V. R., Mai, X. M., Rudensky, A., & Dong, C. (2002) · The Journal of Immunology · doi:10.4049/jimmunol.168.12.6294 · Cited by 295
CD28 costimulation promotes the production of Th2 cytokines
Rulifson, I. C., Sperling, A. I., Fields, P. E., Fitch, F. W., & Bluestone, J. A. (1997) · The Journal of Immunology · doi:10.4049/jimmunol.158.2.658 · Cited by 291
B7‐H3 is a potent inhibitor of human T‐cell activation: No evidence for B7‐H3 and TREML2 interaction
Leitner, J., Klauser, C., Pickl, W. F., Stöckl, J., Majdic, O., Bardet, A. F., Kreil, D. P., Dong, C., Yamazaki, T., Zlabinger, G., et al. (2009) · European Journal of Immunology · doi:10.1002/eji.200839028 · Cited by 290
Wang, W., Lau, R., Yu, D., Zhu, W., Korman, A., & Weber, J. (2009) · International Immunology · doi:10.1093/intimm/dxp072 · Cited by 277
Xu, H., Cheung, I. Y., Guo, H.-F., & Cheung, N.-K. V. (2009) · Cancer Research · doi:10.1158/0008-5472.can-08-4517 · Cited by 264
Flies, D. B., Wang, S., Xu, H., & Chen, L. (2011) · The Journal of Immunology · doi:10.4049/jimmunol.1100660 · Cited by 249
Compartmental intrathecal radioimmunotherapy: results for treatment for metastatic CNS neuroblastoma
Kramer, K., Kushner, B. H., Modak, S., Pandit-Taskar, N., Smith-Jones, P., Zanzonico, P., Humm, J. L., Xu, H., Wolden, S. L., Souweidane, M. M., et al. (2010) · Journal of Neuro-Oncology · doi:10.1007/s11060-009-0038-7 · Cited by 247
Choi, I.-H., Zhu, G., Sica, G. L., Strome, S. E., Cheville, J. C., Lau, J. S., Zhu, Y., Flies, D. B., Tamada, K., & Chen, L. (2003) · The Journal of Immunology · doi:10.4049/jimmunol.171.9.4650 · Cited by 246
The ICOS/ICOSL Pathway Is Required for Optimal Antitumor Responses Mediated by Anti–CTLA-4 Therapy
Fu, T., He, Q., & Sharma, P. (2011) · Cancer Research · doi:10.1158/0008-5472.can-11-1138 · Cited by 243
The signaling networks of the herpesvirus entry mediator (TNFRSF14) in immune regulation
Steinberg, M. W., Cheung, T. C., & Ware, C. F. (2011) · Immunological Reviews · doi:10.1111/j.1600-065x.2011.01064.x · Cited by 243
The ups and downs of T cell costimulation
Jenkins, M. K. (1994) · Immunity · doi:10.1016/1074-7613(94)90086-8 · Cited by 235
Hashiguchi, M., Kobori, H., Ritprajak, P., Kamimura, Y., Kozono, H., & Azuma, M. (2008) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0802423105 · Cited by 227
Zhang, G., Hou, J., Shi, J., Yu, G., Lu, B., & Zhang, X. (2008) · Immunology · doi:10.1111/j.1365-2567.2007.02723.x · Cited by 192
Attenuating Lymphocyte Activity
Compaan, D. M., Gonzalez, L. C., Tom, I., Loyet, K. M., Eaton, D., & Hymowitz, S. G. (2005) · Journal of Biological Chemistry · doi:10.1074/jbc.m507629200 · Cited by 170
B7-H2 Is a Costimulatory Ligand for CD28 in Human
Yao, S., Zhu, Y., Zhu, G., Augustine, M. M., Zheng, L., Goode, D. J., Broadwater, M., Ruff, W. E., Flies, S. J., Xu, H., et al. (2011) · Immunity · doi:10.1016/j.immuni.2011.03.014 · Cited by 165
Cross, A. H., Girard, T. J., Giacoletto, K. S., Evans, R. J., Keeling, R. M., Lin, R. F., Trotter, J. L., & Karr, R. W. (1995) · Journal of Clinical Investigation · doi:10.1172/jci117982 · Cited by 162
Collagen-induced arthritis in the BB rat. Prevention of disease by treatment with CTLA-4-Ig.
Knoerzer, D. B., Karr, R. W., Schwartz, B. D., & Mengle-Gaw, L. J. (1995) · Journal of Clinical Investigation · doi:10.1172/jci118146 · Cited by 161
B7-H3, a potential therapeutic target, is expressed in diffuse intrinsic pontine glioma
Zhou, Z., Luther, N., Ibrahim, G. M., Hawkins, C. E., Vibhakar, R., Handler, M. H., & Souweidane, M. M. (2012) · Journal of Neuro-Oncology · doi:10.1007/s11060-012-1021-2 · Cited by 160
Tekle, C., Nygren, M. K., Chen, Y., Dybsjord, I., Nesland, J. M., Mælandsmo, G. M., & Fodstad, Ø. (2012) · International Journal of Cancer · doi:10.1002/ijc.26238 · Cited by 159
Sun, J., Chen, L.-J., Zhang, G.-B., Jiang, J.-T., Zhu, M., Tan, Y., Wang, H.-T., Lu, B.-F., & Zhang, X.-G. (2010) · Cancer Immunology, Immunotherapy · doi:10.1007/s00262-010-0841-1 · Cited by 159
Römer, P. S., Berr, S., Avota, E., Na, S.-Y., Battaglia, M., ten Berge, I., Einsele, H., & Hünig, T. (2011) · Blood · doi:10.1182/blood-2010-12-319780 · Cited by 153
Cytotoxic T-Lymphocyte–Associated Antigen-4
Salama, A. K. S., & Hodi, F. S. (2011) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-10-2232 · Cited by 153
B7–H3 Ligand Expression by Primary Breast Cancer and Associated With Regional Nodal Metastasis
Arigami, T., Narita, N., Mizuno, R., Nguyen, L., Ye, X., Chung, A. P., Giuliano, A. E., & Hoon, D. S. �. (2010) · Annals of Surgery · doi:10.1097/sla.0b013e3181f1939d · Cited by 148
Immunotherapy earns its spot in the ranks of cancer therapy
Pardoll, D. M., & Drake, C. G. (2012) · The Journal of Experimental Medicine · doi:10.1084/jem.20112275 · Cited by 145
Li, Y., Wang, Q., & Mariuzza, R. A. (2011) · The Journal of Experimental Medicine · doi:10.1084/jem.20102548 · Cited by 144
Zhang, T., Wu, M.-R., & Sentman, C. L. (2012) · The Journal of Immunology · doi:10.4049/jimmunol.1103495 · Cited by 141
Quandt, D., Fiedler, E., Boettcher, D., Marsch, W. C., & Seliger, B. (2011) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-10-2268 · Cited by 137
Clinical Development of the Anti–CTLA-4 Antibody Tremelimumab
Ribas, A. (2010) · Seminars in Oncology · doi:10.1053/j.seminoncol.2010.09.010 · Cited by 134
Tao, R., Wang, L., Han, R., Wang, T., Ye, Q., Honjo, T., Murphy, T. L., MURPHY, K. M. M., & Hancock, W. W. (2005) · The Journal of Immunology · doi:10.4049/jimmunol.175.9.5774 · Cited by 128
Oya, Y., Watanabe, N., Owada, T., Oki, M., Hirose, K., Suto, A., Kagami, S., Nakajima, H., Kishimoto, T., Iwamoto, I., et al. (2008) · Arthritis & Rheumatism · doi:10.1002/art.23674 · Cited by 127
He, Y., Zhang, G., Wang, X., Zhang, H., Yuan, Y., Li, D., & Feng, Z. (2004) · The Journal of Immunology · doi:10.4049/jimmunol.173.8.4919 · Cited by 126
Chen, L., Sun, J., Wu, H., Zhou, S.-M., Tan, Y. Q., Tan, M., Shan, B.-E., Lu, B., & Zhang, X. (2011) · Cancer Immunology Immunotherapy · doi:10.1007/s00262-011-1017-3 · Cited by 125
Álvarez-Quiroga, C., Abud‐Mendoza, C., Doníz-Padilla, L., Juárez-Reyes, A., Monsiváis-Urenda, A. E., Baranda, L., & González‐Amaro, R. (2011) · Journal of Clinical Immunology · doi:10.1007/s10875-011-9527-5 · Cited by 107
Chen, C., Shen, Y., Qu, Q., Chen, X., Zhang, X., & Huang, J. (2012) · Experimental Cell Research · doi:10.1016/j.yexcr.2012.09.006 · Cited by 105
Chen, C., Qu, Q., Shen, Y., Mu, C., Zhu, Y., Zhang, X., & Huang, J. (2011) · Cancer Letters · doi:10.1016/j.canlet.2011.11.017 · Cited by 101
Immunoexpression of B7-H3 in endometrial cancer: Relation to tumor T-cell infiltration and prognosis
Brunner, A. H., Hinterholzer, S., RISS, P. A., Heinze, G., & Brustmann, H. (2011) · Gynecologic Oncology · doi:10.1016/j.ygyno.2011.09.012 · Cited by 100
Regulation of immune and autoimmune responses by ICOS
Dong, C., & Nurieva, R. (2003) · Journal of Autoimmunity · doi:10.1016/s0896-8411(03)00119-7 · Cited by 99
Cutolo, M., & Nadler, S. G. (2013) · Autoimmunity Reviews · doi:10.1016/j.autrev.2013.01.001 · Cited by 95
Tumor expression of B7-H4 predicts poor survival of patients suffering from gastric cancer
Jiang, J., Zhu, Y., Wu, C., Shen, Y., Wei, W., Chen, L., Zheng, X. W., Sun, J., Lu, B., & Zhang, X. (2010) · Cancer Immunology Immunotherapy · doi:10.1007/s00262-010-0900-7 · Cited by 94
B7-H3 Augments the Inflammatory Response and Is Associated with Human Sepsis
Zhang, G., Wang, J., Kelly, J., Gu, G., Hou, J., Zhou, Y., Redmond, H. P., Wang, J. H., & Zhang, X. (2010) · The Journal of Immunology · doi:10.4049/jimmunol.0904020 · Cited by 94
Arigami, T., Uenosono, Y., Hirata, M., Yanagita, S., Ishigami, S., & Natsugoe, S. (2011) · Cancer Science · doi:10.1111/j.1349-7006.2011.01877.x · Cited by 92
Diagnosis value of serum B7-H3 expression in non-small cell lung cancer
Zhang, G., Xu, Y., Lü, X., Huang, H., Zhou, Y., Lu, B., & Zhang, X. (2009) · Lung Cancer · doi:10.1016/j.lungcan.2009.01.017 · Cited by 89
B7-H3 Over Expression in Prostate Cancer Promotes Tumor Cell Progression
Yuan, H., Wei, X., Zhang, G., Li, C., Zhang, X., & Hou, J. (2011) · The Journal of Urology · doi:10.1016/j.juro.2011.04.103 · Cited by 89
Expression of Immunosuppresive B7-H3 Ligand by Hormone-Treated Prostate Cancer Tumors and Metastases
Chavin, G., Sheinin, Y. M., Crispen, P. L., Boorjian, S. A., Roth, T. J., Rangel, L. J., Blute, M. L., Sebo, T. J., Tindall, D., Kwon, E. D., et al. (2009) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-08-2262 · Cited by 82
Azuma, T., Zhu, G., Xu, H., Rietz, A. C., Drake, C. G., Matteson, E. L., & Chen, L. (2009) · PLoS Medicine · doi:10.1371/journal.pmed.1000166 · Cited by 81
B7-H4–deficient mice display augmented neutrophil-mediated innate immunity
Zhu, G., Augustine, M. M., Azuma, T., Luo, L., Yao, S., Anand, S., Rietz, A. C., Huang, J., Xu, H., Flies, A. S., et al. (2008) · Blood · doi:10.1182/blood-2008-01-133223 · Cited by 81
Hobo, W. A., Norde, W. J., Schaap, N. P., Fredrix, H., Maas, F., Schellens, K., Falkenburg, J. H. F., Korman, A. J., Olive, D., van der Voort, R., et al. (2012) · The Journal of Immunology · doi:10.4049/jimmunol.1102807 · Cited by 70
Yao, Y., Wang, X., Jin, K., Zhu, J., Wang, Y., Xiong, S., Mao, Y. Q., & Zhou, L. (2008) · Journal of Neuro-Oncology · doi:10.1007/s11060-008-9601-x · Cited by 67
Tissue-specific expression of B7x protects from CD4 T cell–mediated autoimmunity
Wei, J., Loke, P., Zang, X., & Allison, J. P. (2011) · The Journal of Experimental Medicine · doi:10.1084/jem.20100639 · Cited by 65
B7-H4 Expression Promotes Tumorigenesis in Ovarian Cancer
Cheng, L., Jiang, J., Gao, R., Wei, S., Nan, F., Li, S., & Kong, B. (2009) · International Journal of Gynecological Cancer · doi:10.1111/igc.0b013e3181ad0fa2 · Cited by 64
Arigami, T., Uenosono, Y., Ishigami, S., Hagihara, T., Haraguchi, N., & Natsugoe, S. (2011) · World Journal of Surgery · doi:10.1007/s00268-011-1186-4 · Cited by 58
Aloia, L., Parisi, S., Fusco, L., Pastore, L., & Russo, T. (2009) · Journal of Biological Chemistry · doi:10.1074/jbc.m109.077156 · Cited by 56
Katayama (2011) · International Journal of Oncology · doi:10.3892/ijo.2011.949 · Cited by 55
Early Treatment of NOD Mice With B7-H4 Reduces the Incidence of Autoimmune Diabetes
Wang, X., Hao, J., Metzger, D. L., Mui, A., Ao, Z., Akhoundsadegh, N., Langermann, S., Liu, L. L., Chen, L., Ou, D., et al. (2011) · Diabetes · doi:10.2337/db11-0375 · Cited by 54
B7-H4 Treatment of T Cells Inhibits ERK, JNK, p38, and AKT Activation
Wang, X., Hao, J., Metzger, D. L., Ao, Z., Chen, L., Ou, D., Verchere, C. B., Mui, A., & Warnock, G. L. (2012) · PLoS ONE · doi:10.1371/journal.pone.0028232 · Cited by 51
Kellner, C., Maurer, T., Hallack, D., Repp, R., van de Winkel, J. G. J., Parren, P. W. H. I., Valerius, T., Humpe, A., Gramatzki, M., & Peipp, M. (2012) · The Journal of Immunology · doi:10.4049/jimmunol.1201321 · Cited by 51
Wang, X., Hao, J., Metzger, D. L., Mui, A., Ao, Z., Verchere, C. B., Chen, L., Ou, D., & Warnock, G. L. (2009) · Transplantation · doi:10.1097/tp.0b013e318195e5fa · Cited by 49
Prevot, N., Briet, C., Lassmann, H., Tardivel, I., Roy, E., Morin, J., Mak, T. W., Tafuri, A., & Boîtard, C. (2010) · European Journal of Immunology · doi:10.1002/eji.201040416 · Cited by 49
GI24 enhances tumor invasiveness by regulating cell surface membrane‐type 1 matrix metalloproteinase
Sakr, M., Takino, T., Domoto, T., Nakano, H., Wong, R. W.-C., Sasaki, M., Nakanuma, Y., & Sato, H. (2010) · Cancer Science · doi:10.1111/j.1349-7006.2010.01675.x · Cited by 46
Toward experimental assessment of receptor occupancy: TGN1412 revisited
Waibler, Z., Sender, L. Y., Kamp, C., Müller-Berghaus, J., Liedert, B., Schneider, C. K., Löwer, J., & Kalinke, U. (2008) · Journal of Allergy and Clinical Immunology · doi:10.1016/j.jaci.2008.07.049 · Cited by 40
Arigami, T., Uenosono, Y., Hirata, M., Hagihara, T., Yanagita, S., Ishigami, S., & Natsugoe, S. (2010) · Journal of Surgical Oncology · doi:10.1002/jso.21722 · Cited by 40
Song, H., Park, G., Kim, Y.-S., Hur, I., Kim, H., Ryu, J. W., Lee, H.-K., Cho, D.-H., Choi, I.-H., Lee, W. J., et al. (2008) · Cancer Letters · doi:10.1016/j.canlet.2008.02.067 · Cited by 36
Park, G. B., Song, H., Kim, Y. S., Sung, M., Ryu, J. W., Lee, H., Cho, D., Kim, D., Lee, W. J., & Hur, D. Y. (2009) · Immunology · doi:10.1111/j.1365-2567.2009.03111.x · Cited by 34
B7x in the Periphery Abrogates Pancreas-Specific Damage Mediated by Self-reactive CD8 T Cells
Lee, J. S., Scandiuzzi, L., Ray, A., Wei, J., Hofmeyer, K. A., Abadi, Y. M., Loke, P., Lin, J., Yuan, J. D., SERREZE, D. V., et al. (2012) · The Journal of Immunology · doi:10.4049/jimmunol.1201241 · Cited by 34
Chen, X., Zhang, G., Li, Y., Xing, F., Wan, F., Zhang, L., Wang, J., & Zhang, X. (2008) · Journal of Molecular Neuroscience · doi:10.1007/s12031-008-9133-z · Cited by 32
B7-H4 transfection prolongs β-cell graft survival
Yuan, C.-L., Xu, J., Tong, J., Yang, H., He, F., Gong, Q., Xiong, P., Duan, L., Fang, M., Tan, Z., et al. (2009) · Transplant Immunology · doi:10.1016/j.trim.2009.03.007 · Cited by 29
Possible involvement of soluble B7-H4 in T cell-mediated inflammatory immune responses
Kamimura, Y., Kobori, H., Piao, J., Hashiguchi, M., Matsumoto, K., Hirose, S., & Azuma, M. (2009) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2009.08.144 · Cited by 28
Chen, C., Zhu, Y.-B., Shen, Y., Zhu, Y., Zhang, X., & Huang, J.-A. (2012) · Journal of Immunotherapy · doi:10.1097/cji.0b013e31824212c4 · Cited by 27
B7-H4 Induces Donor-Specific Tolerance in Mouse Islet Allografts
Wang, X., Hao, J., Metzger, D. L., Mui, A., Ao, Z., Verchere, C. B., Chen, L., Ou, D., & Warnock, G. L. (2011) · Cell Transplantation · doi:10.3727/096368911x582750 · Cited by 17
Enhanced T Cell Immunity by B7-H4 Downregulation in Nonsmall-Cell Lung Cancer Cell Lines
Sun, S.-Q., Jiang, C.-G., Lin, Y., Jin, Y.-L., & Huang, P.-L. (2012) · Journal of International Medical Research · doi:10.1177/147323001204000211 · Cited by 14
Cited by
Macrophages as regulators of tumour immunity and immunotherapy
DeNardo, D. G., & Ruffell, B. (2019) · Nature Reviews Immunology · doi:10.1038/s41577-019-0127-6 · Cited by 2,528
Mittal, D., Gubin, M. M., Schreiber, R. D., & Smyth, M. J. (2014) · Current Opinion in Immunology · doi:10.1016/j.coi.2014.01.004 · Cited by 1,471
Novel immune checkpoint targets: moving beyond PD-1 and CTLA-4
Qin, S., Xu, L., Yi, M., Yu, S., Wu, K., & Luo, S. (2019) · Molecular Cancer · doi:10.1186/s12943-019-1091-2 · Cited by 1,145
Coinhibitory Pathways in the B7-CD28 Ligand-Receptor Family
Schildberg, F. A., Klein, S. R., Freeman, G. J., & Sharpe, A. H. (2016) · Immunity · doi:10.1016/j.immuni.2016.05.002 · Cited by 542
γδ T cells in homeostasis and host defence of epithelial barrier tissues
Nielsen, M. M., Witherden, D. A., & Havran, W. L. (2017) · Nature Reviews Immunology · doi:10.1038/nri.2017.101 · Cited by 479
Metadata
- Authors
- Ceeraz, S., Nowak, E. C., & Noelle, R. J.
- Venue
- Trends in Immunology
- Publisher
- Elsevier BV
- Published
- 2013-11
- Volume
- 34
- Issue
- 11
- Pages
- 556-563
- ISSN
- 1471-4906 (ISSN-L)
- OpenAlex
- W2062549560
- Cited by
- 307
- References
- 112
- FWCI
- 2.42
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.